Clinical Trial Update: Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing polyethylene glycol versus lactulose for hepatic encephalopathy in cirrhosis patients is ongoing with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• LACTULOSE (Lactulose)
• Polyethylene Glycol (polyethylene glycol)

Snippet

Sponsor: Aga Khan University | Conditions: Hepatic Encephalopathy | Phase 4 | Status: UNKNOWN